12 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

LPO OPTION FOR DRAGER INTENSIVE CARE VENTILATOR SAVINA

FDA 510(k)
FDA Class 2 ·Anesthesiology

UNKNOWN SCREW

FDA Adverse Event
Injury ·BIOMET ORTHOPEDICS·Product code PAO·February 4, 2015

SOFT K. AND SOFT K. TORIC (XYLOFICON A) SOFT (HYDROPHILLIC) KERATOCONUS CONTACT LENS FOR DAILY WEAR

FDA 510(k)
FDA Class 2 ·Ophthalmic

PLEURX PLEURAL CATHETER AND DRAINAGE KITS

FDA 510(k)
FDA Class 2 ·Cardiovascular

ORTHOBLAST

FDA Adverse Event
Injury ·INTEGRA LIFE SCIENCES·Product code MBP·September 27, 2013

PERCLOSE PROGLIDE 6F SUTURE MEDIATED CLOSURE (SMC) SYSTEM

FDA Adverse Event
Injury ·AV-TEMECULA-CT·Product code MGB·August 13, 2018

VITALITY 2

FDA Adverse Event
Malfunction ·GUIDANT CRM CLONMEL IRELAND·Product code LWS·April 8, 2013

9900

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·March 22, 2011

XCEED NITINOL SELF-EXPANDING TRANSHEPATIC BILIARY STENT SYSTEM

FDA Adverse Event
Malfunction ·ABBOTT VASCULAR REDWOOD CITY·Product code FGE·May 8, 2008

COPELAND THN SHL COCR/HA HUMS3

FDA Adverse Event
Injury ·BIOMET UK LTD.·Product code KWS·August 28, 2025

CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024

Aespire View. This anesthesia gas machine is intended to provide general inhalation anesthesia and ventilatory support to patients and are to be used only by medical professionals trained and qualified in the administration of general anesthesia.

FDA Enforcement
Class I ·Ongoing·Datex-Ohmeda, Inc.·October 30, 2024